Struggling with medications for mental health conditions?
Medicare recognizes that pharmacogenomic testing is an important part of mental health treatment and has a coverage policy in place. In this coverage policy, there are specific medical necessity requirements that your provider must note for this test to be covered. Myriad Neuroscience will work with your provider to collect this information and submit the claim for payment.
If the test is considered non-covered, your clinician will need to submit an Advanced Beneficiary Notice signed by you before we can deliver the GeneSight® test. By signing the ABN, you agree to pay the full cost of the test and will be billed accordingly. Learn more about ABN’s here.
If you decide to use your insurance and we determine that your cost will exceed $330, we will contact you before processing the test and before billing you to make sure you would like to proceed.
If your cost is $100 or more, we offer an interest-free payment plan that allows you to spread your payments over multiple months.
Billing any insurance provider takes time. The process may be lengthy; here is what to expect and when.
We receive your sample. When we receive your sample, we will confirm your cost. If it’s more than $330, we will contact you before processing your test.
We bill your insurance. We process your test and submit a claim to your insurance company.
You may receive an explanation of benefits (EOB). Your insurance company will process your claim. They may send you an EOB. This is not a bill.
You receive your bill. Once your insurance claim is completed, we will send you a statement of what you owe. This is a bill. You can pay on-line, by phone, or by mail.
If you are an older adult and are experiencing depressive symptoms, you aren’t alone. As many as 7 million Americans 65 years of age and older suffer from geriatric depression, according to the Centers for Disease Control.
It’s important to get help to address depression. Left untreated, the CDC says depression in the elderly can “complicate chronic conditions such as heart disease, diabetes, and stroke; increase health care costs; and often accompany functional impairment and disability.” Further, depression can lead to “higher mortality from suicide and cardiac disease.”
For more information on depression treatment for older Americans, click below: